BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11869506)

  • 1. [A clinico-pathological study of neuroendocrine tumors in stomach].
    Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of gastric neuroendocrine tumors and its clinicopathologic significance.
    Yu JY; Wang LP; Meng YH; Hu M; Wang JL; Bordi C
    World J Gastroenterol; 1998 Apr; 4(2):158-161. PubMed ID: 11819263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects].
    Bordi C; Azzoni C; D'Adda T; Caruana P; Carlinfante G
    Pathologe; 1997 Jul; 18(4):313-21. PubMed ID: 9380606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
    Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
    Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary gastric endocrine tumors].
    Liu SM; Liu XY; Zou SM; Wei GL; Sun YT
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):38-42. PubMed ID: 12760802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune metaplastic atrophic gastritis, G cell hyperplasia and neuroendocrine tumor of stomach].
    Chen G; Huang S
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):34-5. PubMed ID: 24713247
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite glandular-endocrine cell carcinomas of the stomach: clinicopathologic and methylation study.
    Lee EJ; Park SM; Maeng L; Lee A; Kim KM
    APMIS; 2005 Sep; 113(9):569-76. PubMed ID: 16218931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration.
    Tsolakis AV; Stridsberg M; Grimelius L; Portela-Gomes GM; Falkmer SE; Waldum HL; Janson ET
    J Clin Gastroenterol; 2008 Apr; 42(4):381-8. PubMed ID: 18277901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oesophageal and gastric pathology: early neoplastic lesions: case n(o) 8: an endocrine tumour of the stomach].
    Scoazec JY
    Ann Pathol; 2011 Oct; 31(5):390-5. PubMed ID: 21982248
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gastric glomus tumors expressing synaptophysin: clinicopathologic and immunohistochemical analyses].
    Wang JC; Jin XF; Weng SX; Xu C; Gan MF
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):756-759. PubMed ID: 29136687
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
    Trinh VQ; Shi C; Ma C
    Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine neoplasm of the stomach. Study of thirteen cases].
    Angeles-Angeles A
    Gac Med Mex; 2005; 141(3):207-13. PubMed ID: 16025986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.